ENTRY       D12185                      Drug
NAME        Patritumab (USAN/INN)
FORMULA     C6542H10072N1740O2038S40
EXACT_MASS  146896.6813
MOL_WEIGHT  146987.0063
SEQUENCE    (Heavy chain)
            QVQLQQWGAG LLKPSETLSL TCAVYGGSFS GYYWSWIRQP PGKGLEWIGE INHSGSTNYN
            PSLKSRVTIS VETSKNQFSL KLSSVTAADT AVYYCARDKW TWYFDLWGRG TLVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKRVEPKSC DKTHTCPPCP APELLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSREEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            DIEMTQSPDS LAVSLGERAT INCRSSQSVL YSSSNRNYLA WYQQNPGQPP KLLIYWASTR
            ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCQQYYST PRTFGQGTKV EIKRTVAAPS
            VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
            LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
            (Disulfide bridge: H22-H95, H144-H200, H220-L220, H226-H'226, H229-H'229, H261-H321, H367-H425, H'22-H'95, H'144-H'200, H'220-L'220, H'261-H'321, H'367-H'425, L23-L94, L140-L200, L'23-L'94, L'140-L'200)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
TARGET      ERBB3 (HER3) [HSA:2065] [KO:K05084]
  PATHWAY   hsa04010(2065)  MAPK signaling pathway
            hsa04012(2065)  ErbB signaling pathway
            hsa04151(2065)  PI3K-Akt signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                ERBB3 (HER3)
                 D12185  Patritumab (USAN/INN)
DBLINKS     CAS: 1262787-83-6
///
